ProMIS Neurosciences, Inc.
PMN
$10.57
$0.080.76%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/12/2026
-
Seeking Alpha - Healthcare
5/12/2026
-
Globe Newswire
5/4/2026
-
MarketBeat
4/25/2026
-
Tickeron - Technical Analysis
4/24/2026
-
MarketBeat
4/21/2026
-
Tickeron - Technical Analysis
4/16/2026
-
Tickeron - Technical Analysis
4/15/2026
-
Tickeron - Technical Analysis
4/14/2026
-
Tickeron - Stocks
4/14/2026
-
Tickeron - Stocks
4/13/2026
-
Newsfile Corp. - News Releases
4/11/2026
-
Tickeron - Technical Analysis
4/10/2026
-
Tickeron - Technical Analysis
4/10/2026
-
Tickeron - Technical Analysis
3/25/2026
-
TipRanks Financial Blog
3/25/2026
-
Globe Newswire
3/18/2026
-
The Fly
3/18/2026
-
Globe Newswire
3/10/2026
-
MarketBeat
3/5/2026
-
MarketBeat
3/5/2026
-
MarketBeat
3/5/2026
-
MarketBeat
2/24/2026
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, March 25, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 11 and 15 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
416 847 6898
Address
1920 Yonge Street
Toronto, ON M4S 3E2
Toronto, ON M4S 3E2
Country
Year Founded
--
Business Description
Sector
ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada. The company’s...
more